Postmenopausal inflammation Past few decades most of the research focused on molecular link among oxidative stress and inflammation in response to aging and numerous metabolic and pathological consequences have been recognized, which have etiological origin of inflammation and the term inflammaging has been coined [11-13]
What exists is preclinical, and it is thin: Rodent and in-vitro work described procognitive and synaptogenic effects (McCoy 2013, PMID 23055539 now under an Expression of Concern
The risk of side effects increases with other medical conditions such as immunocompromised conditions (diabetes, HIV, being on immune suppressants such as prednisone) that can be associated with poor skin healing and increased risk of infection
Cowdry) 10331068 (Paul B Hoeber, Inc, 1928)
Patients and clinicians who want to weigh in have until July 9, 2026 to submit comments that the committee will see directly